Stadler Jeanne
Therapie. 2014 Jan-Feb;69(1):25-30. doi: 10.2515/therapie/2014010. Epub 2014 Apr 4.
Developmental and reproduction toxicology studies (DART) are an essential part of the non-clinical dossier for a regulatory submission. They are performed according to internationally recognized and regulatory protocols. They allow a reasonable risk evaluation when a drug is given at any stage of the reproduction cycle. They study impact of the test compound on reproductive functions of both sexes, on pregnancy and embryo/fetal development, parturition and postnatal development of the progeny. The data interpretation and the establishment of safety margins lead to the edition of specific recommendations in the summary of product characteristics (SPC) and directly to the prescribers.
发育和生殖毒理学研究(DART)是监管申报非临床资料的重要组成部分。这些研究按照国际认可的监管方案进行。当在生殖周期的任何阶段给予药物时,它们有助于进行合理的风险评估。它们研究受试化合物对两性生殖功能、妊娠、胚胎/胎儿发育、分娩及子代产后发育的影响。数据解读和安全边际的确定会在产品特性摘要(SPC)中形成具体建议,并直接提供给处方医生。